Billionaire Guo Guangchang's Shanghai Fosun Pharmaceutical Group is considering a sale of Indian drugmaker Gland Pharma after receiving interest from potential buyers, people familiar with the matter said.
Fosun Pharma, a listed arm of Chinese conglomerate Fosun International, has been working with an adviser as it informally gauges interest in its controlling stake in Gland, the people said.
This story is from the November 30, 2022 edition of Business Standard.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the November 30, 2022 edition of Business Standard.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
'Hope ICAI takes inputs from all for network rules'
\"THREE SECTORS WHICH STAND OUT BASED ON CURRENT TRACTION ARE TECHNOLOGY, HEALTHCARE AND RETAIL & CONSUMER JJ PwC India is committed to fully engaging with relevant professional bodies and regulators, says chairperson SANJEEV KRISHAN in an interview with Raghav Aggarwal in New Delhi.
'There is no impact of elections on the market'
At a time when the industry is expecting an election impact on commercial vehicle (CV) sales, SHENU AGARWAL, managing director (MD) and chief executive officer (CEO), Ashok Leyland, believes that the segment may do well during the first half of this financial year.
Top 3 IT majors train over 775,000 in GenAI skills
The top three Indian IT firmsTata Consultancy Services (TCS), Infosys and Wipro - collectively trained over 775,000 employees in generative AI (GenAI) capability by the end of 2023-24, according to an analysis of GenAI-trained workforce of leading companies in India in this sector.
GCPL posts ₹1,893 cr loss in March quarter
FMCG major Godrej Consumer Products on Monday reported a consolidated loss of 1,893.21 crore in the fourth quarter ended March 31, 2024, impacted by exceptional items related to impairment of brand and goodwill, and loss on sale of business in Africa.
Sebi no to market hour extension proposal: NSE
Stock brokers not on the same page over costs, tech needs
FSIB meet on May 21-22 to select SBI's next chief
The Financial Services Institutions Bureau (FSIB) is likely to meet on May 21-22 to recommend a candidate for the post of chairman of State Bank of India (SBI), said a person familiar with the matter.
KKR acquires Healthium Medtech for 7,000 cr
Global investment firm KKR on Monday announced acquiring Bengaluru-based medical devices company Healthium Medtech from an affiliate of funds advised by private equity firm Apax Partners.
Modi Missing, It Is Pawar Vs Pawar In Baramati
Maharashtra's Baramati constituency is witnessing a high-octane battle between the sitting MP Supriya Sule and NCP's Sunetra Pawar, whose husband Ajit Pawar recently cut political ties with uncle Sharad Pawar.
Breweries stir up barrels with mercury rising
Firms ramp up production, diversify offerings on record summer sales forecast Bengaluru,
Spice row: Norms for pesticide residue stringent, says gov
AKSHARA SRIVASTAVA & SANKET KOUL New Delhi, 5 May India has some of the most stringent norms for pesticide residues limit in food items, the government asserted on Sunday, amid reports that the regulator permits higher pesticide residues limit in herbs and spices.
